Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. 1994

V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
Department of Immunology, INSERM U28, Hôpital Broussais, Paris, France.

We have observed that decreased plasma levels of C3 in the serum of three children with poststreptococcal acute glomerulonephritis (PSAGN) at the time of presentation were associated with the presence of C3NeF activity in purified serum IgG from the patients. C3NeF activity was determined using a sensitive assay measuring the ability of patients' IgG to stabilize a preformed cell-bound alternative pathway convertase complex. C3NeF activity of patients' IgG decreased within weeks as plasma levels of C3 progressively returned to normal values. C3NeF activity became undetectable within 1-4 months following normalization of plasma C3 levels. Our observations suggest that early alternative pathway-dependent hypocomplementaemia, a cardinal feature of PSAGN, is mediated by the transient expression of C3NeF autoantibody activity by patients' IgG.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003178 Complement C3 Nephritic Factor An IgG autoantibody against the ALTERNATIVE PATHWAY C3 CONVERTASE, found in serum of patients with MESANGIOCAPILLARY GLOMERULONEPHRITIS. The binding of this autoantibody to C3bBb stabilizes the enzyme thus reduces the actions of C3b inactivators (COMPLEMENT FACTOR H; COMPLEMENT FACTOR I). This abnormally stabilized enzyme induces a continuous COMPLEMENT ACTIVATION and generation of C3b thereby promoting the assembly of MEMBRANE ATTACK COMPLEX and cytolysis. C3 NeF,C3 NeF IgG Autoantibodies,C3 NeF IgG Autoantibody,C3NeF IgG Autoantibodies,C3NeF IgG Autoantibody,C 3 Nephritic Factor,C3 Nephritic Factor,Complement 3 Nephritic Factor,Autoantibody, C3NeF IgG,IgG Autoantibody, C3NeF
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
March 1976, Clinical nephrology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
December 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
September 1992, Clinical and experimental immunology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
April 1983, Clinical and experimental immunology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
January 1995, British journal of rheumatology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
August 1990, Clinical immunology and immunopathology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
July 1977, The New England journal of medicine,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
February 2015, Pediatric nephrology (Berlin, Germany),
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
October 1983, Clinical and experimental immunology,
V Frémeaux-Bacchi, and L Weiss, and C Demouchy, and A May, and S Palomera, and M D Kazatchkine
August 1979, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!